(Q84585354)
Statements
Intranasal administration of recombinant human cartilage glycoprotein-39 as a treatment for rheumatoid arthritis: a phase II, multicentre, double-blind, randomised, placebo-controlled, parallel-group, dose-finding trial (English)
Robert B M Landewé
Jos G A Houbiers
Filip Van den Bosch
Joanna in't Hout
Jan H Meijerink
Frank H J van den Hoogen
George A W Bruyn
Jacques M G W Wouters
Alexandre E Voskuyl
Jacob M van Laar
Johannes J W Bijlsma
Désirée M F M van der Heijde
Ferdinand C Breedveld
Leo B A van de Putte
André M M Miltenburg
Filip de Keyser
23 September 2009